Exercise and Diet for Fatigue in Lymphoma

Recruiting in Palo Alto (17 mi)

Overseen ByChristopher Jensen, MD MSCR

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: UNC Lineberger Comprehensive Cancer Center

No Placebo Group

Trial Summary

What is the purpose of this trial?This health services study will assess a multidisciplinary intervention program directed at fatigue mitigation among patients diagnosed with indolent lymphomas. Specifically, 30 subjects with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and 10 subjects with Follicular Lymphoma (FL), marginal zone lymphoma (MZL), lymphoplasmacytic lymphoma (LPL), Waldenström's Macroglobulinemia, or Cutaneous T Cell Lymphoma (CTCL) will be included.

Eligibility Criteria

This trial is for patients with certain slow-growing lymphomas, including CLL/SLL, Follicular Lymphoma, Marginal Zone Lymphoma, Waldenstrom's Macroglobulinemia, and Cutaneous T-Cell Lymphoma. It aims to help those experiencing cancer-related fatigue.

Inclusion Criteria

I am 18 years old or older.

I have been diagnosed with a slow-growing type of lymphoma.

I often feel very tired.

Exclusion Criteria

I have other types of cancer besides the one being treated.

Participant Groups

The study tests a supportive care program focusing on exercise and diet to combat fatigue in lymphoma patients. It will include 30 subjects with CLL/SLL and 10 subjects with other specified types of indolent lymphomas.

1Treatment groups

Experimental Treatment

Group I: Patients who are with chronic lymphocytic leukemia/small lymphocytic lymphomaExperimental Treatment2 Interventions

Patients who are with chronic lymphocytic leukemia/small lymphocytic lymphoma were assessed and received exercise and diet programs.